SANDOZ INC. et al v. UNITED THERAPEUTICS CORPORATION et al

  1. April 29, 2024

    Sandoz Says Biopharma Biz Added 'Poison' To Market

    More than $160 million separate generic-drug maker Sandoz Inc. and biopharmaceutical firm United Therapeutics Corp. in their estimates of damages suffered by Sandoz when the other company effectively blocked the sale of Sandoz's generic version of a hypertension medication, according to opening statements Monday during a bench trial in New Jersey federal court.

  2. June 10, 2021

    Sandoz Will Get To Search Rival CFO's Phone In Antitrust Row

    United Therapeutics Corp. will have to turn over its chief financial officer's text messages for rival drugmaker Sandoz Inc.'s antitrust suit, although Sandoz must also relinquish evidence related to getting government approval of its competing product, a New Jersey federal judge ruled Thursday.

  3. July 01, 2020

    Sandoz Dodges Sanctions Bid In Antitrust Dispute

    A New Jersey federal judge has rebuffed biopharmaceutical company United Therapeutics and infusion pump maker Smiths Medical's bid to impose sanctions on Sandoz and its marketing firm in an antitrust dispute, ruling that they attempted to correct their accidental filing of an unredacted document that revealed trade secrets.

  4. January 30, 2020

    NJ Court Declines To Toss Sandoz Suit Over Blocked Generic

    Sandoz failed Wednesday to win the injunction it was after to halt the maker of a hypertension drug from effectively blocking the sale of its generic version, but it managed to hold off an effort to dismiss the suit altogether.

  5. October 16, 2019

    Sandoz Revealed Trade Secrets In Antitrust Suit, Court Told

    Sandoz Inc. and its marketing firm were hit with a sanctions motion late Tuesday alleging they violated a confidentiality order by revealing trade secrets in an unredacted filing in the case docket for the generic-drug maker's antitrust claims against United Therapeutics Corp.

  6. April 17, 2019

    BioPharma Firm, Device Maker Blocked Generic, Sandoz Says

    Biopharmaceutical firm United Therapeutics Corp. colluded with the only manufacturer of an infusion pump for injecting its brand-name hypertension drug to muscle out Sandoz's generic alternative, Sandoz alleged in New Jersey federal court.